These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 22039288

  • 21. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.
    Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ.
    Am J Clin Pathol; 2003 Nov; 120(5):725-31. PubMed ID: 14608899
    [Abstract] [Full Text] [Related]

  • 22. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital.
    Ly M, Antoine M, Dembélé AK, Levy P, Rodenas A, Touré BA, Badiaga Y, Dembélé BK, Bagayogo DC, Diallo YL, Koné AA, Callard P, Bernaudin JF, Diallo DA.
    Oncology; 2012 Nov; 83(5):257-63. PubMed ID: 22964749
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
    Tsang JY, Ni YB, Chan SK, Shao MM, Law BK, Tan PH, Tse GM.
    Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
    [Abstract] [Full Text] [Related]

  • 26. Identification of a basal-like subtype of breast ductal carcinoma in situ.
    Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.
    Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
    [Abstract] [Full Text] [Related]

  • 27. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
    Arslan C, Isik M, Guler G, Kulac I, Solak M, Turker B, Ozisik Y, Altundag K.
    Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
    [Abstract] [Full Text] [Related]

  • 28. Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast.
    Cho LC, Hsu YH.
    Kaohsiung J Med Sci; 2008 May; 24(5):227-32. PubMed ID: 18508419
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.
    Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A.
    J Clin Pathol; 2014 Sep; 67(9):768-71. PubMed ID: 24996432
    [Abstract] [Full Text] [Related]

  • 33. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
    Wenhui Z, Shuo L, Dabei T, Ying P, Zhipeng W, Lei Z, Xiaohui H, Jingshu G, Hongtao S, Qingyuan Z.
    Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
    [Abstract] [Full Text] [Related]

  • 34. Expression of oestrogen receptor-beta in apocrine carcinomas of the breast.
    Honma N, Takubo K, Akiyama F, Kasumi F, Sawabe M, Arai T, Hosoi T, Yoshimura N, Harada N, Younes M, Sakamoto G.
    Histopathology; 2007 Mar; 50(4):425-33. PubMed ID: 17448017
    [Abstract] [Full Text] [Related]

  • 35. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.
    Kneubil MC, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A, Lohsiriwat V, Manconi A, Martella S, Santillo B, Petit JY, Rietjens M.
    Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.
    Cubukcu E, Kanat O, Fatih Olmez O, Kabul S, Canhoroz M, Avci N, Deligonul A, Hartavi M, Cubukcu S, Olmez F, Kurt E, Evrensel T, Gokgoz S, Manavoglu O.
    J BUON; 2013 Mar; 18(2):359-65. PubMed ID: 23818346
    [Abstract] [Full Text] [Related]

  • 38. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
    Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW.
    Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
    Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, Van Limbergen E, Weltens C, Van den Bogaert W, Smeets A, Vergote I, Christiaens MR, Drijkoningen M.
    Breast Cancer Res Treat; 2008 Jul; 110(1):153-9. PubMed ID: 17687649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.